Idera Pharmaceuticals, Inc. Gains 41.07%
Tue, Jun 22, 2021 at 05:30 PM
Idera Pharmaceuticals, Inc. (IDRA:NASDAQ) shot up at $1.58, representing a gain of 41.1%. On Mon, Jun 21, 2021, IDRA:NASDAQ hit a New 2-Week Low of $1.12. From Mon, Jun 07, 2021, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Apr 07, 2021 at $1.59 with a volume of 17M+, and its share price has been moving sideways in recent weeks.
About Idera Pharmaceuticals, Inc. (IDRA:NASDAQ)
Idera Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in the discovery, development and commercialization of novel therapeutics for oncology and rare diseases.
Top 10 Gainers:
- ALF (ALF:NASDAQ), 108.85%
- County Bancorp, Inc. (ICBK:NASDAQ), 47.29%
- Idera Pharmaceuticals, Inc. (IDRA:NASDAQ), 41.07%
- 3D Systems Corporation (DDD:NYSE), 27.67%
- SilverSun Technologies, Inc. (SSNT:NASDAQ), 24.26%
- Globalstar, Inc. (GSAT:NYSEMKT), 23.18%
- GROY (GROY:NYSEMKT), 22.35%
- Beyond Air, Inc. (XAIR:NASDAQ), 20.98%
- SharpSpring, Inc. (SHSP:NASDAQ), 19.84%
- Atossa Therapeutics, Inc. (ATOS:NASDAQ), 19.19%